BONIVA - Once-Monthly Medication for Postmenopausal Osteoporosis Treatment
Links shared publicly online about this topic.
- 1,289total visits
BONIVA - Once-Monthly Medication for Postmenopausal Osteoporosis Treatment
View full resource at boniva.com
Tags: Bone, Osteoporosis, Osteoporosis Medication, Mineral, Sodium, Drug, Boniva, Bonviva
Most Recently Shared on March 25, 2010 at 2:36 pm By:
Today is the 5th anniversary of BONIVA® (ibandronate sodium) Tablets. Learn more about Boniva: http://tinyurl.com/ykgr9lf
Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion - Drugs.com MedNews
drugs.com — “Eli Lilly and Company (NYSE LLY) today announced that data on EVISTA (raloxifene HCl tablets) therapy for more than three years was published online in Current” View full resource at drugs.com
Most Recently Shared on August 9, 2011 at 5:31 pm By:
Drugs and Devices OW OW Health
Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published... http://bit.ly/qMlU0F #drug
Rheumatology Article | Postmenopause Women Osteoporosis Osteoporosis, Postmenopausal
mdlinx.com — “Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US” View full resource at mdlinx.com
Most Recently Shared on April 13, 2011 at 9:03 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-... http://bit.ly/elvvvD #Rheumatology
Loyola Physician Helps Develop National Guidelines For Osteoporosis
medicalnewstoday.com — “The American Association of Clinical Endocrinologists (AACE) has released new medical guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Loyola physician Pauline Camacho, M” View full resource at medicalnewstoday.com
Most Recently Shared on January 20, 2011 at 5:05 pm By:
MNT Bones/Orthopedic Health News
Loyola Physician Helps Develop National Guidelines For Osteoporosis http://mnt.to/3QdS #bones #orthopedics
AACE releases new medical guidelines for diagnosis and treatment of postmenopausal osteoporosis
news-medical.net — “The American Association of Clinical Endocrinologists (AACE) has released new medical guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Loyola physician Pauline Camacho, MD, was part of a committee that developed the guidelines to manage this major public health issue.” View full resource at news-medical.net
Most Recently Shared on January 20, 2011 at 2:39 pm By:
Osteoporosis News: AACE releases new medical guidelines for diagnosis and treatment of postmenopausal osteoporos... http://bit.ly/hHT9A9
Loyola Physician Helps Develop National Guidelines for Osteoporosis
newswise.com — “The American Association of Clinical Endocrinologists (AACE) has released new medical guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Loyola physician Pauline Camacho, MD, was part of a committee that developed the guidelines to manage this major public health issue.” View full resource at newswise.com
Most Recently Shared on January 19, 2011 at 8:28 pm By:
newswise Health News and Health Communicator
Loyola Physician Helps Develop National Guidelines for Osteoporosis: The American Association of Clinical Endocr... http://bit.ly/dPGEav
AACE Releases New Guidelines For Clinical Practice For The Diagnosis And Treatment Of Postmenopausal Osteoporosis
medicalnewstoday.com — “Today the American Association of Clinical Endocrinologists (AACE) released new medical guidelines for the accurate diagnosis and effective ethical treatment of postmenopausal osteoporosis in affe” View full resource at medicalnewstoday.com
Most Recently Shared on January 11, 2011 at 2:05 pm By:
MNT Bones/Orthopedic Health News
AACE Releases New Guidelines For Clinical Practice For The Diagnosis And Treatment Of Postmenopausal Osteoporosis http://mnt.to/3PQD
New guidelines for accurate diagnosis, effective ethical treatment of postmenopausal osteoporosis
news-medical.net — “Today the American Association of Clinical Endocrinologists released new medical guidelines for the accurate diagnosis and effective ethical treatment of postmenopausal osteoporosis in affected patients.” View full resource at news-medical.net
Most Recently Shared on January 11, 2011 at 8:09 am By:
Osteoporosis News: New guidelines for accurate diagnosis, effective ethical treatment of postmenopausal osteopor... http://bit.ly/fN06Vh
Nursing Medical News about osteoporosis
mdlinx.com — “New osteoporosis treatment approved for postmenopausal women” View full resource at mdlinx.com
Most Recently Shared on June 28, 2010 at 9:22 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
New osteoporosis treatment approved for postmenopausal women: American Pharmacists Association http://bit.ly/9KpUBz #Nursing
Rheumatology Medical News about Osteoporosis, Postmenopausal
mdlinx.com — “Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenopausal Women With Type 2 Diabetes Mellitus Accompanied With Osteoporosis” View full resource at mdlinx.com
Most Recently Shared on June 9, 2010 at 9:15 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenop... http://bit.ly/akfaR2 #Rheumatology
Cardiology Medical News about Osteoporosis, Postmenopausal
mdlinx.com — “Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenopausal Women With Type 2 Diabetes Mellitus Accompanied With Osteoporosis” View full resource at mdlinx.com
Most Recently Shared on June 9, 2010 at 1:14 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmen... http://bit.ly/dgCX8Z #cardio #mdlinx
FDA approves Amgen's osteoporosis drug Prolia | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “In a long-awaited development, the first drug in a new class of osteoporosis medications was approved Tuesday by the Food and Drug Administration. The drug is Amgen's injectable treatment, Prolia. The medication, for postmenopausal women with osteoporosis, is expected to...” View full resource at latimesblogs.latimes.com
Most Recently Shared on June 1, 2010 at 11:00 pm By:
LA Times Health News Health News
FDA approves Amgen's osteoporosis drug Prolia http://lat.ms/ct18B4
Rheumatology Medical News about Adrenal Glands Osteoporosis Osteoporosis, Postmenopausal Teriparatide
mdlinx.com — “Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis” View full resource at mdlinx.com
Most Recently Shared on March 29, 2010 at 7:11 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
#Rheumatology Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis: Osteoporosis... http://bit.ly/bNHhUw
Rheumatology Medical News about Age Distribution Osteoporosis, Postmenopausal Risedronate
mdlinx.com — “Assessment of the Relationship Between Age and the Effect of Risedronate Treatment in Women with Postmenopausal Osteoporosis: A Pooled Analysis of Four Studies” View full resource at mdlinx.com
Most Recently Shared on March 25, 2010 at 12:55 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
#Rheumatology Assessment of the Relationship Between Age and the Effect of Risedronate Treatment in Women with Pos... http://bit.ly/9dn97e
Family Med Medical News about Osteoporosis Postmenopause Women lasofoxifene
mdlinx.com — “Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene” View full resource at mdlinx.com
Most Recently Shared on January 29, 2010 at 9:20 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Med: Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on l http://url4.eu/1GEbJ
Rheumatology Medical News about Osteoporosis Postmenopause Women lasofoxifene
mdlinx.com — “Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene” View full resource at mdlinx.com
Most Recently Shared on January 29, 2010 at 9:13 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Rheum: Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on http://url4.eu/1GEUs
Advertisement
